Increased glomerular cytosolic phospholipase A2 activity of OLETF rats with early diabetes

被引:12
|
作者
Furuya, Y
Tagami, S
Hasegawa, A
Ishii, J
Hirokawa, J
Yoshimura, H
Honda, T
Sakaue, S
Aoki, K
Murakami, M
Kudo, I
Kawakami, Y
机构
[1] Hokkaido Univ, Sch Med, Dept Med 1, Kita Ku, Sapporo, Hokkaido 060, Japan
[2] Showa Univ, Sch Pharmaceut Sci, Dept Hlth Chem, Tokyo 142, Japan
关键词
cytosolic phospholipase A(2); diabetic nephropathy; glomeruli; hyperfiltration; OLETF rats;
D O I
10.1055/s-0029-1212116
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In view of the potential role of prostaglandins (PGs) in development of glomerular hyperfiltration leading to diabetic nephropathy, we studied the temporal relationship of the activity of cytosolic phospholipase A(2) (cPLA(2)), a rate-limiting enzyme for eicosanoid biosynthesis, with hyperfiltration and the histological changes in glomeruli using OLETF rats, a model for non-insulin-dependent diabetes mellitus (NIDDM). Diabetes mellitus and associated histopathological changes, which developed spontaneously by 30-46 weeks after birth of OLETF rats, were accompanied by approximately 65% increase in glomerular cPLA(2) activity that showed significant correlations with elevated plasma glucose levels and creatinine clearance. Moreover, mesangial cells cultured for 5 days with high glucose exhibited approximately 2-fold higher cPLA(2) activity than those cultured with physiologic level of glucose. These data suggest that increased glomerular cPLA(2) activity leads to production of PGs, which may promote the progression of early diabetic glomerular hyperfiltration and subsequent diabetic nephropathy.
引用
收藏
页码:299 / 305
页数:7
相关论文
共 50 条
  • [1] Increased activity of glomerular cytosolic phospholipase A2 in NIDDM rats.
    Furuya, Y
    Tagami, S
    Yoshimura, H
    Horida, T
    Sakaue, S
    Aoki, K
    Ishii, J
    Hasegawa, A
    Hirokawa, J
    Kawakami, Y
    DIABETOLOGIA, 1997, 40 : 2018 - 2018
  • [2] Increased renal and vascular cytosolic phospholipase A2 activity in rats with cirrhosis and ascites
    Niederberger, M
    Ginès, P
    Martin, PY
    St John, J
    Woytaszek, P
    Xu, LM
    Tsai, P
    Nemenoff, RA
    Schrier, RW
    HEPATOLOGY, 1998, 27 (01) : 42 - 47
  • [3] Increased levels of cytosolic phospholipase A2 in dyslexics
    MacDonnell, LEF
    Skinner, FK
    Eward, PE
    Glen, AIM
    Glen, ACA
    Macdonald, DJ
    Boyle, RM
    Horrobin, DF
    PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2000, 63 (1-2): : 37 - 39
  • [4] Regulation of cytosolic phospholipase A2 activity
    Bunt, G
    van Rossum, GSA
    van den Bosch, H
    Verkleij, AJ
    Boonstra, J
    MOLECULAR MECHANISMS OF TRANSCELLULAR SIGNALING: FROM MEMBRANE RECEPTORS TO TRANSCRIPTION FACTORS, 1999, 309 : 109 - 125
  • [5] Regulation of cytosolic phospholipase A2 activity by sphingolipids
    Shimizu, M
    Matsumoto, Y
    Hirabayashi, T
    Murayama, T
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2005, 97 : 144P - 144P
  • [6] Fluorogenic probes to monitor cytosolic phospholipase A2 activity
    Ng, Cheng Yang
    Kwok, Timothy Xiong Wei
    Tan, Francis Chee Kuan
    Low, Chian-Ming
    Lam, Yulin
    CHEMICAL COMMUNICATIONS, 2017, 53 (11) : 1813 - 1816
  • [7] Protective role for cytosolic phospholipase A2α in autoimmune diabetes of mice
    Oikawa, Y
    Yamato, E
    Tashiro, F
    Yamamoto, M
    Uozumi, N
    Shimada, A
    Shimizu, T
    Miyazaki, J
    FEBS LETTERS, 2005, 579 (18): : 3975 - 3978
  • [8] Cytosolic phospholipase A2 activity during the ongoing cell cycle
    Van Rossum, GSAT
    Vlug, AS
    Van den Bosch, H
    Verkleij, AJ
    Boonstra, J
    JOURNAL OF CELLULAR PHYSIOLOGY, 2001, 188 (03) : 321 - 328
  • [9] Enhancement of a liver form of cytosolic phospholipase A2 activity by methylmercury
    Huh, DH
    Kang, MS
    Sohn, DH
    Na, DS
    Kim, DK
    JOURNAL OF BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1998, 31 (02): : 189 - 195
  • [10] Role for cytosolic phospholipase A2α in autoimmune diabetes in nonobese diabetic mice
    Oikawa, Y
    Yamato, E
    Tashiro, F
    Yamamoto, M
    Uozumi, N
    Shimada, A
    Shimizu, T
    Miyazaki, JI
    DIABETES, 2005, 54 : A308 - A308